These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2897164)

  • 1. Visual compatibility of esmolol hydrochloride and various injectable drugs during simulated Y-site injection.
    Colucci RD; Cobuzzi LE; Halpern NA
    Am J Hosp Pharm; 1988 Mar; 45(3):630-2. PubMed ID: 2897164
    [No Abstract]   [Full Text] [Related]  

  • 2. Compatibility of esmolol hydrochloride with morphine sulfate and fentanyl citrate during simulated Y-site administration.
    Karnatz NN; Wong J; Kesler H; Baaske DM; Speicher ER
    Am J Hosp Pharm; 1988 Feb; 45(2):368-71. PubMed ID: 2896460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of esmolol hydrochloride and sodium nitroprusside in intravenous admixtures.
    Karnatz NN; Wong J; Baaske DM; Johnson JH; Speicher ER; Herbranson DE
    Am J Hosp Pharm; 1989 Jan; 46(1):101-4. PubMed ID: 2565685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual compatibility of labetalol hydrochloride injection with various injectable drugs during simulated Y-site injection.
    Colucci RD; Cobuzzi LE; Halpern NA
    Am J Hosp Pharm; 1988 Jun; 45(6):1357-8. PubMed ID: 3414706
    [No Abstract]   [Full Text] [Related]  

  • 5. Visual compatibility of esmolol hydrochloride and furosemide in 5% dextrose or 0.9% sodium chloride injections.
    Thompson DF; Thompson GD
    Am J Hosp Pharm; 1987 Dec; 44(12):2740. PubMed ID: 3434585
    [No Abstract]   [Full Text] [Related]  

  • 6. Visual compatibility of tacrolimus with commonly used drugs during simulated Y-site injection.
    Min DI; Brown T; Hwang GC
    Am J Hosp Pharm; 1992 Dec; 49(12):2964-6. PubMed ID: 1282779
    [No Abstract]   [Full Text] [Related]  

  • 7. Stability of esmolol hydrochloride in intravenous solutions.
    Baaske DM; Dykstra SD; Wagenknecht DM; Karnatz NN
    Am J Hosp Pharm; 1994 Nov; 51(21):2693-6. PubMed ID: 7856582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual compatibility of neuromuscular blocking agents with various injectable drugs during simulated Y-site injection.
    Savitsky ME
    Am J Hosp Pharm; 1990 Apr; 47(4):820-1. PubMed ID: 1969713
    [No Abstract]   [Full Text] [Related]  

  • 9. Esmolol--a short-acting i.v. beta-blocker.
    Med Lett Drugs Ther; 1987 Jun; 29(742):57-8. PubMed ID: 2884558
    [No Abstract]   [Full Text] [Related]  

  • 10. Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures.
    Foushee JA; Meredith P; Fox LM; Grace E
    Int J Pharm Compd; 2016; 20(4):328-332. PubMed ID: 28333677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administration.
    Lor E; Sheybani T; Takagi J
    Am J Hosp Pharm; 1991 Apr; 48(4):744-6. PubMed ID: 2042678
    [No Abstract]   [Full Text] [Related]  

  • 12. Visual compatibility of morphine sulfate and meperidine hydrochloride with other injectable drugs during simulated Y-site injection.
    Pugh CB; Pabis DJ; Rodriguez C
    Am J Hosp Pharm; 1991 Jan; 48(1):123-5. PubMed ID: 2000871
    [No Abstract]   [Full Text] [Related]  

  • 13. Visual compatibility of haloperidol lactate with 0.9% sodium chloride injection or injectable critical-care drugs during simulated Y-site injection.
    Outman WR; Monolakis J
    Am J Hosp Pharm; 1991 Jul; 48(7):1539-41. PubMed ID: 1882889
    [No Abstract]   [Full Text] [Related]  

  • 14. Visual compatibility of amsacrine with selected drugs during simulated Y-site injection.
    Trissel LA; Chandler SW; Folstad JT
    Am J Hosp Pharm; 1990 Nov; 47(11):2525-8. PubMed ID: 2278268
    [No Abstract]   [Full Text] [Related]  

  • 15. Visual compatibility of idarubicin hydrochloride with selected drugs during simulated Y-site injection.
    Turowski RC; Durthaler JM
    Am J Hosp Pharm; 1991 Oct; 48(10):2181-4. PubMed ID: 1781476
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of efficacy of intravenous diltiazem and esmolol in terminating supraventricular tachycardia.
    Gupta A; Naik A; Vora A; Lokhandwala Y
    J Assoc Physicians India; 1999 Oct; 47(10):969-72. PubMed ID: 10778689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-bolus injection of esmolol for treatment of intraoperative tachycardia.
    Ford SR
    Anesth Analg; 1991 Apr; 72(4):565-6. PubMed ID: 1672491
    [No Abstract]   [Full Text] [Related]  

  • 18. Is intravenous esmolol an acceptable substitute for an inadequate anesthetic?
    Ginsburg RS; Lippmann M
    Anesth Analg; 1992 May; 74(5):776-7. PubMed ID: 1348915
    [No Abstract]   [Full Text] [Related]  

  • 19. Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection.
    Trissel LA; Tramonte SM; Grilley BJ
    Am J Hosp Pharm; 1991 May; 48(5):988-92. PubMed ID: 1830190
    [No Abstract]   [Full Text] [Related]  

  • 20. Compatibility of amiodarone hydrochloride with vasopressin during simulated Y-site administration.
    Ramaley CC; Li F; Du C
    Int J Pharm Compd; 2013; 17(5):436-8. PubMed ID: 24459790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.